Obesity and overweight crisis keeps getting worse
The numbers tell a stark story. One in eight people worldwide now live with obesity, and the rate has more than doubled among adults since 1990. What was once framed as a problem tied to wealthier nations has become a global pattern, touching nearly every country and crossing every income level. How obesity is measured […]
Survodutide hits where other weight loss drugs miss
Phase 3 data from the SYNCHRONIZE-1 trial shows the experimental drug reducing visceral and liver fat while preserving lean muscle mass in adults with obesity. Most weight loss medications work by suppressing appetite. Survodutide does that too, but the experimental drug developed by Boehringer Ingelheim is drawing attention for what it […]
Ozempic and vision loss: what the research actually shows
A small but striking study links semaglutide and tirzepatide to serious eye conditions, raising questions researchers say are worth taking seriously even if the risk remains low. Weight loss medications have reshaped how doctors approach obesity and blood sugar management. Ozempic and Zepbound, which contain semaglutide and tirzepatide respectively, have become […]
Celebrities who’ve taken Ozempic and GLP-1 weight loss drugs
Ozempic and its GLP-1 counterparts are no longer Hollywood’s best kept secret. What started as whispered speculation about sudden transformations on red carpets has turned into a growing chorus of celebrity voices speaking openly about weight loss medication. Their willingness to share is doing something quietly powerful and shifting the conversation from shame toward honesty. […]
The pros, cons, and considerations of taking ozempic or other drugs for weight loss
Ozempic has become one of the most talked about medications in recent memory, and for good reason. A growing number of people who spent years struggling with weight have finally found something that works. But behind the Ozempic hype is a more layered story, one that deserves a closer look before anyone rushes to their […]
GLP-1 drugs are quietly reshaping how America shops and eats
More than 20% of US households now include at least one GLP-1 user, and the ripple effects on grocery spending, fast food, fashion, and beauty products are accelerating faster than any consumer shift in recent memory. When Megan McDonald started taking the GLP-1 drug Zepbound two years ago, she was not thinking about […]
Ozempic’s New Pill Form Could Change Who Has Access
Novo Nordisk has begun selling an oral version of semaglutide in the United States under the Ozempic name, a move that extends one of the most recognized drug brands in recent memory into a format that does not require an injection. The pill became available on May 4, 2026, at more than 70,000 pharmacies nationwide, […]
Weight loss shown to reverse heart muscle damage caused by severe obesity
New research in Science found that losing 10% of body weight through GLP-1 therapy restored near-normal heart muscle function in patients with obesity-related heart failure. For years, the medical community has understood that obesity strains the heart. What has been less clear is whether that strain can be undone. A […]
DIY peptide injections are sending people to the ER
What started as a niche interest among bodybuilders has quietly spread to suburban moms, white collar professionals and affluent antiaging enthusiasts and now doctors at high-end longevity clinics are dealing with the fallout. People are increasingly sourcing injectable peptides online, from grey market sellers, or secondhand from friends treating the practice. A peptide is a […]
New study finds 1 gene variant that boosts GLP-1 results
GLP-1 receptor agonists like semaglutide and tirzepatide have become some of the most talked about medications in modern medicine, reshaping how millions of people approach weight loss. But a sweeping new study suggests that the results people experience may have less to do with willpower or lifestyle and more to do with what is written […]